Rossella Cavallo
A5102778936- Global Cancer Incidence and Screening
- Cervical Cancer and HPV Research
- Childhood Cancer Survivors' Quality of Life
- Acute Lymphoblastic Leukemia research
- Economic and Financial Impacts of Cancer
- Cancer Risks and Factors
- Endometrial and Cervical Cancer Treatments
- Glioma Diagnosis and Treatment
- BRCA gene mutations in cancer
- Cutaneous Melanoma Detection and Management
- Lymphoma Diagnosis and Treatment
- Multiple and Secondary Primary Cancers
- Immunotherapy and Immune Responses
- Advances in Oncology and Radiotherapy
- Breast Cancer Treatment Studies
- Genital Health and Disease
- Genetic factors in colorectal cancer
- Breast Implant and Reconstruction
- Thyroid Cancer Diagnosis and Treatment
- Cell Image Analysis Techniques
- Hematopoietic Stem Cell Transplantation
- Melanoma and MAPK Pathways
- Colorectal and Anal Carcinomas
- Palliative Care and End-of-Life Issues
- Ocular Oncology and Treatments
University of Salerno
2021-2024
ASL Roma
2023-2024
Swiss Cancer League
2021
Institut National du Cancer
2021
Cancer Institute (WIA)
2021
Cancer Research Foundation
2021
London School of Hygiene & Tropical Medicine
2021
Centre International De Reference Chantal Biya
2021
•Italy will have 4 million cancer survivors in 2030 (6.9% of the population), half diagnosed at least 10 years earlier.•From 2018 to 2030, complete prevalence increase by 1.5% per year.•As many as 7 out 8 prevalent cases same life expectancy general population.•Ten after diagnosis, 96% not die from cancer.•Prevalence estimates are essential improve consistent, data-driven control planning. BackgroundThe number and projections necessary meet healthcare needs patients, while data on cure...
Abstract People alive many years after breast (BC) or colorectal cancer (CRC) diagnoses are increasing. This paper aimed to estimate the indicators of cure and complete prevalence for Italian patients with BC CRC by stage age. A total 31 Cancer Registries (47% population) data until 2017 were included. Mixture models allowed estimation net survival (NS); fraction (CF); time (TTC, 5‐year conditional NS >95%); (who will not die cancer); already cured (prevalent living longer than TTC). 2.6%...
To describe the procedures to derive complete prevalence and several indicators of cancer cure from population-based registries. Cancer registry data (47% Italian population) were used calculate limited duration for 62 types by sex registry. The incidence survival models, needed completeness index (R) prevalence, evaluated likelihood ratio tests visual comparison. A sensitivity analysis was conducted explore effect on using different R indexes. Mixture models estimate net (NS); life...
Abstract This study aims to estimate long-term survival, cancer prevalence, and several cure indicators for Italian women with gynecological cancers. Thirty-one registries, representing 47% of the female population, were included. Mixture models used net fraction, time (when 5-year conditional survival becomes > 95%), prevalence (women who will not die cancer), already cured (living longer than cure). In 2018, 0.4% (121 704) alive after diagnosis corpus uteri cancer, 0.2% (52 551)...
The long-term increase in survival from cutaneous malignant melanoma (CMM) is generally attributed to the decreasing trend tumour thickness, single most important prognostic factor.
The global increase in incidence of cutaneous malignant melanoma (CMM) occurring the past decades has been partly attributed to increased diagnostic scrutiny early lesions, with a potential phenomenon overdiagnosis. reported positive linear relation between skin biopsy rate and CMM is compatible this hypothesis.We explored ecological association trends annual dermatologic office visit rates, rates situ invasive by tumour thickness category, mortality Emilia-Romagna Region (northern...
(1) Objective: In many Western countries, survival from vulvar squamous cell carcinoma (VSCC) has been stagnating for decades or increased insufficiently a clinical perspective. Italy, previous studies on cancer have not taken into consideration pooled patients with and vaginal cancer. To bridge this knowledge gap, we report the trend in between 1990 2015. (2) Methods: Thirty-eight local registries covering 49% of national female population contributed records 6274 patients. Study endpoints...
Objective: To evaluate short-term (2008–2017) cancer incidence trends in Italy for individuals aged 20-49 years by sex and type. Methods: Observational study from population-based data collected 20 Italian Cancer Registries, covering 33% of the population. The age-standardized rates (ASRs), overall stratified area, sex, site or type, major age groups (i.e., 20-39, 40-49), were computed. Results: In 2008-2017, almost two times higher women than age-corresponding men (202.2 vs 112.4 per...
Abstract Background The number of patients living after a cancer diagnosis is increasing, especially thyroid (TC). This study aims at evaluating both the risk second primary (SPC) in TC and as SPC. Methods We analyzed two population‐based cohorts individuals with or other neoplasms diagnosed between 1998 2012, 28 Italian areas covered by registries. Standardized incidence ratios (SIRs) SPC were stratified sex, age, time since first cancer. Results A total 38,535 1,329,624 cancers included....
A recent research project using data from a total of 40 cancer registries has provided new epidemiologic insights into the results efforts for melanoma control in Italy between 1990s and last decade. In this article, authors present summary commentary their findings. Incidence increased significantly throughout study period both sexes. However, rates showed stabilization or decrease men women aged below 35 years. The risk disease successive cohorts born until 1973 (women) 1975 (men) while...
Objective: Five-year net survival and conditional from vulvar squamous cell carcinoma (VSCC) in Italy have shown no progress during the past three decades. This study aims to estimate complete prevalence multiple indicators of cure for VSCC patients.Methods: Thirty-one population-based cancer registries covering 47% Italian female population provided data 8,070 incident (1978-2017) cases (83% aged ≥65 years). Mixture models were used several patients. Results: In 2018, patients alive...
Introduction: The number of patients living after a cancer diagnosis is increasing, especially hemolymphopoietic and thyroid (TC). This study aims at evaluating both the risk second in TC as cancer. Methods: Two population-based cohorts aged up to 84 years were identified from 28 Italian registries 1998–2012. first included cancers with cancers. Standardized incidence ratios (SIR) SPC stratified by sex, age, time since diagnosed within 2 months are not computation cancer-specific SIRs....